home / stock / clsd / clsd quote
$3.25 Last:
-6.88% Change Percent:
$3.49 Open:
$3.25 Previous Close:
$3.56 High:
$3.18 Low:
490,951 Volume:
02/25/2021 04:55:23 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-02-25 | 3.49 | 3.25 | 3.56 | 3.18 | 490,951 |
2021-02-24 | 3.53 | 3.49 | 3.71 | 3.46 | 188,242 |
2021-02-23 | 3.75 | 3.5 | 3.85 | 3.03 | 814,516 |
2021-02-22 | 3.93 | 3.8 | 4.25 | 3.8 | 506,118 |
2021-02-19 | 3.48 | 3.85 | 4.03 | 3.4255 | 679,894 |
2021-02-18 | 3.62 | 3.47 | 3.63 | 3.3 | 410,346 |
2021-02-17 | 3.86 | 3.58 | 3.86 | 3.54 | 376,600 |
2021-02-16 | 3.85 | 3.86 | 4.2 | 3.81 | 444,384 |
2021-02-15 | 3.9 | 3.83 | 3.91 | 3.75 | 309,018 |
2021-02-12 | 3.9 | 3.83 | 3.91 | 3.75 | 308,912 |
2021-02-11 | 4.25 | 3.86 | 4.34 | 3.7 | 866,482 |
2021-02-10 | 4 | 4.25 | 4.53 | 3.823 | 1,395,349 |
2021-02-09 | 3.84 | 3.89 | 4.01 | 3.77 | 603,526 |
2021-02-08 | 3.47 | 3.82 | 4.0573 | 3.4 | 1,016,103 |
2021-02-05 | 3.5 | 3.4 | 3.55 | 3.26 | 389,095 |
2021-02-04 | 3.59 | 3.5 | 3.59 | 3.38 | 254,744 |
2021-02-03 | 3.55 | 3.51 | 3.59 | 3.35 | 503,696 |
2021-02-02 | 3.12 | 3.25 | 3.26 | 3.07 | 430,058 |
2021-02-01 | 3.07 | 3.07 | 3.1778 | 2.97 | 788,599 |
2021-01-29 | 3.31 | 3.13 | 3.44 | 3.11 | 424,592 |
Clearside Biomedical Inc. Company Name:
CLSD Stock Symbol:
NASDAQ Market:
Clearside Biomedical Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
- Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders - - CLS-AX will also be featured at the upcoming virtual Angiogenesis, Exudation, and Degeneration 2021 conference on February 13, 2021 - ALPHARETTA, ...
ALPHARETTA, Ga., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the first p...
ALPHARETTA, Ga., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that it has ente...